Rational engineering of a miniprotein that reproduces the core of the CD4 site interacting with HIV-1 envelope glycoprotein.
暂无分享,去创建一个
J C Gluckman | C. Roumestand | C. Vita | A. Ménez | L. Ylisastigui | L Martin | C Vita | E. Drakopoulou | J. Vizzavona | J. Gluckman | S. Rochette | L. Martin | Y. S. Yang | A. Benjouad | A Ménez | C Roumestand | Y S Yang | E Drakopoulou | J Vizzavona | S Rochette | L Ylisastigui | A Benjouad | J. Gluckman | Abdelaziz Benjouad | Loïc Martin | Claudio Vita | André Ménez | Yinshan Yang
[1] W. Hendrickson,et al. CD4: its structure, role in immune function and AIDS pathogenesis, and potential as a pharmacological target. , 1991, Current opinion in biotechnology.
[2] A. Braisted,et al. Minimizing a binding domain from protein A. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[3] S. Harrison,et al. The human immunodeficiency virus gp120 binding site on CD4: delineation by quantitative equilibrium and kinetic binding studies of mutants in conjunction with a high-resolution CD4 atomic structure , 1992, The Journal of experimental medicine.
[4] C. Vita,et al. Novel miniproteins engineered by the transfer of active sites to small natural scaffolds. , 1998, Biopolymers.
[5] H. Buc,et al. HIV-1 reverse transcription. A termination step at the center of the genome. , 1994, Journal of molecular biology.
[6] M. Uhlén,et al. Scaffolds for engineering novel binding sites in proteins. , 1997, Current opinion in structural biology.
[7] Joseph Sodroski,et al. CD4-induced interaction of primary HIV-1 gp120 glycoproteins with the chemokine receptor CCR-5 , 1996, Nature.
[8] T. Malliavin,et al. Gifa V. 4: A complete package for NMR data set processing , 1996, Journal of biomolecular NMR.
[9] D. Littman,et al. Fusion-competent vaccines: broad neutralization of primary isolates of HIV. , 1999, Science.
[10] Q. Sattentau,et al. Identification of the residues in human CD4 critical for the binding of HIV , 1989, Cell.
[11] D. Brainard,et al. Color, contrast sensitivity, and the cone mosaic. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[12] T. Matthews,et al. Peptides corresponding to a predictive alpha-helical domain of human immunodeficiency virus type 1 gp41 are potent inhibitors of virus infection. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[13] Peter D. Kwong,et al. Crystal structure of an HIV-binding recombinant fragment of human CD4 , 1990, Nature.
[14] L. Ylisastigui,et al. HIV type 1 V3 peptide constructs act differently on HIV type 1 infection of peripheral blood lymphocytes and macrophages. , 1997, AIDS research and human retroviruses.
[15] W. Hendrickson,et al. Structures of an HIV and MHC binding fragment from human CD4 as refined in two crystal lattices. , 1994, Structure.
[16] J. Sodroski,et al. The HIV-1 envelope glycoproteins: fusogens, antigens, and immunogens. , 1998, Science.
[17] Flavio Toma,et al. Structural basis for functional diversity of animal toxins , 1992 .
[18] D. Littman. Chemokine Receptors: Keys to AIDS Pathogenesis? , 1998, Cell.
[19] S. Harrison,et al. Peptide Ligands to Human Immunodeficiency Virus Type 1 gp120 Identified from Phage Display Libraries , 1999, Journal of Virology.
[20] J. Sodroski,et al. Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody , 1998, Nature.
[21] C. Roumestand,et al. Refined structure of charybdotoxin: common motifs in scorpion toxins and insect defensins. , 1991, Science.
[22] C. Weiss,et al. Capture of an early fusion-active conformation of HIV-1 gp41 , 1998, Nature Structural Biology.
[23] Luc Montagnier,et al. T-lymphocyte T4 molecule behaves as the receptor for human retrovirus LAV , 1984, Nature.
[24] F M Poulsen,et al. Accurate measurements of coupling constants from two-dimensional nuclear magnetic resonance spectra of proteins and determination of phi-angles. , 1991, Journal of molecular biology.
[25] K. M. Hwang,et al. Synthetic CD4 peptide derivatives that inhibit HIV infection and cytopathicity. , 1988, Science.
[26] D. Weiner,et al. Design and synthesis of a CD4 beta-turn mimetic that inhibits human immunodeficiency virus envelope glycoprotein gp120 binding and infection of human lymphocytes. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[27] William C. Olson,et al. CD4-dependent, antibody-sensitive interactions between HIV-1 and its co-receptor CCR-5 , 1996, Nature.
[28] D. Weiner,et al. Synthetic CD4 exocyclics inhibit binding of human immunodeficiency virus type 1 envelope to CD4 and virus replication in T lymphocytes , 1997, Nature Biotechnology.
[29] C. Mullineaux,et al. A proportion of photosystem II core complexes are decoupled from the phycobilisome in light‐state 2 in the cyanobacterium Synechococcus 6301 , 1990 .
[30] M. Lazdunski,et al. Solution conformation of leiurotoxin I (scyllatoxin) by 1H nuclear magnetic resonance , 1990, FEBS letters.
[31] L. Presta,et al. Mapping the CD4 binding site for human immunodeficiency virus by alanine-scanning mutagenesis. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[32] C. Roumestand,et al. Scorpion toxins as natural scaffolds for protein engineering. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[33] Q. Sattentau. HIV gp120: double lock strategy foils host defences. , 1998, Structure.
[34] M. Billeter,et al. MOLMOL: a program for display and analysis of macromolecular structures. , 1996, Journal of molecular graphics.
[35] C. Vita,et al. Changing the Structural Context of a Functional -Hairpin , 1996, The Journal of Biological Chemistry.
[36] B. Cunningham,et al. Minimization of a Polypeptide Hormone , 1995, Science.
[37] M. Lazdunski,et al. Scyllatoxin, a blocker of Ca(2+)-activated K+ channels: structure-function relationships and brain localization of the binding sites. , 1992, Biochemistry.
[38] K. Wüthrich. NMR of proteins and nucleic acids , 1988 .
[39] J. Moore. Simple methods for monitoring HIV-1 and HIV-2 gp120 binding to soluble CD4 by enzyme-linked immunosorbent assay: HIV-2 has a 25-fold lower affinity than HIV-1 for soluble CD4. , 1990, AIDS.
[40] M. Greaves,et al. The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus , 1984, Nature.